Parithera is pioneering an AI-ready, clinical-grade liquid biopsy platform for single-cell analysis. Our platform is ideally positioned to study cancer treatment resistance.
Products, services, technology
ExTrace:
Our fully automated liquid biopsy platform uses proprietary microfluidics to capture high-purity single-cell data from blood samples.
ExPlore:
An AI-driven analysis software that transforms raw sequencing data into actionable insights.
Cooperation possibilities
We are seeking partnerships with ADC, bispecific & CAR-T developers.
- https://www.parithera.com
- Send an email
- Antoine Herzog
